Literature DB >> 30554045

Study of the bioaccumulation of tinzaparin in renally impaired patients when given at prophylactic doses - The STRIP study.

D Projean1, S Lalonde2, J Morin2, E Nogues2, A Séguin2, A Vincent2, J P Lafrance3, V Masson4, J Kassis5, J Fafard4, M Lordkipanidzé6.   

Abstract

Entities:  

Keywords:  Anticoagulant; Bioaccumulation; Kidney disease; Prophylaxis; Renal insufficiency; Venous thromboembolism

Mesh：

Substances：

Year:  2018        PMID： 30554045     DOI： 10.1016/j.thromres.2018.11.031

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

Review 1.  Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis.

Authors:  Corinne Frere; Carme Font; Francis Esposito; Benjamin Crichi; Philippe Girard; Nicolas Janus
Journal:  Support Care Cancer       Date:  2021-10-06       Impact factor: 3.359

Review 2.  Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications.

Authors:  Hélène Helfer; Virginie Siguret; Isabelle Mahé
Journal:  Am J Cardiovasc Drugs       Date:  2020-06       Impact factor: 3.571

3.  Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review.

Authors:  I A Vathiotis; N K Syrigos; E P Dimakakos
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.